Home » Topics » BioWorld Science

BioWorld Science
RSS

Theratechnologies-Beaufour Ipsen agreement on TH-9506

Oct. 25, 1996

Fourth viral protease structure solved by Agouron

Oct. 25, 1996

AM-4055 available for licensing

Oct. 25, 1996

Thymosin alpha 1 effective and safe for the treatment of hepatitis B

Oct. 25, 1996

New prokinetic agents from Janssen

Oct. 25, 1996

Safety and efficacy of oral H. pylori vaccine demonstrated in patients

Oct. 25, 1996

CCK-B/gastrin antagonists from Chugai

Oct. 25, 1996

Anti-H. pylori agents discovered by Terumo

Oct. 25, 1996

Muscarinic antagonists from Yamanouchi

Oct. 25, 1996

Transgenic ATIII proven safe in healthy volunteers

Oct. 25, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Cytospire raises £61M series A to target EGFR in solid tumors
BioWorld
Next-generation T-cell engager (TCE) specialist Cytospire Therapeutics Ltd. has raised £61 million (US$82.7 million) in a series A round, equipping it to advance...